Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data

Abstract

We analyzed pertussis reporting, death, hospitalization, and serodiagnostic data from 1976 to 1998 to help explain the cause of the 1996 pertussis outbreak in the Netherlands. The unexpected outbreak was detected by an increase in pertussis reporting and by other surveillance methods. In 1996, according to reporting and serologic data, the increase in pertussis incidence among (mostly unvaccinated) children less than 1 year of age was similar to the increase in hospital admissions. Among older (mostly vaccinated) persons, the increase in hospital admissions was relatively small. The increase in pertussis incidence was higher among vaccinated than among unvaccinated persons of all ages. This resulted in lower estimates of vaccine effectiveness. The proportion of pertussis infections resulting in recognizable symptoms may have increased among vaccinated persons because of a mismatch of the vaccine strain and circulating Bordetella pertussis strains. The small immunogenicity profile of the Dutch vaccine may have resulted in greater vulnerability to antigenic changes in B. pertussis.

References 23

1. 1.

   Andrews R., Herceg A., Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell. 1997;21(11):145-148.

   Not in our library10.33321/cdi.1997.21.30

2. 2.

   Baker J. D., Halperin S. A., Edwards K., Miller B., Decker M., Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr. 1992;121(4):523-527.

   Not in our library10.1016/s0022-3476(05)81138-2

3. 3.

   Bass J. W., Stephenson S. R. The return of pertussis. Pediatr Infect Dis J. 1987;6(2):141-144.

   Not in our library10.1097/00006454-198702000-00001

4. 4.

   Bass J. W., Wittler R. R. Return of epidemic pertussis in the United States. Pediatr Infect Dis J. 1994;13(5):343-345.

   Not in our library10.1097/00006454-199405000-00002

5. 5.

   Bentsi-Enchill A. D., Halperin S. A., Scott J., MacIsaac K., Duclos P. Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine. 1997;15(3):301-306.

   Not in our library10.1016/s0264-410x(96)00176-4

6. 6.

   De Serres G., Boulianne N., Douville Fradet M., Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep. 1995;21(5):45-48.

   Not in our library

7. 7.

   Farrington C. P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993;22(4):742-746.

   Not in our library10.1093/ije/22.4.742

8. 8.

   Guris D., Strebel P. M., Tachdjian R., Bardenheier B., Wharton M., Hadler S. C. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis. 1997;176(2):456-463.

   Not in our library10.1086/514064

9. 9.

   Güriş D., Strebel P. M., Bardenheier B., Brennan M., Tachdjian R., Finch E., Wharton M., Livengood J. R. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28(6):1230-1237.

   Not in our library10.1086/514776

10. 10.

    Isacson J., Trollfors B., Taranger J., Zackrisson G., Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J. 1993;12(4):284-288.

    Not in our library10.1097/00006454-199304000-00005

11. 11.

    Mastrantonio P., Spigaglia P., van Oirschot H., van der Heide H. G., Heuvelman K., Stefanelli P., Mooi F. R. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology. 1999;145(Pt 8):2069-2075.

    Not in our library10.1099/13500872-145-8-2069

12. 12.

    Milord F. Resurgence of pertussis in Montérégie, Quebec--1990-1994. Can Commun Dis Rep. 1995;21(5):40-44.

    Not in our library

13. 13.

    Mooi F. R., He Q., van Oirschot H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun. 1999;67(6):3133-3134.

    Not in our library10.1128/iai.67.6.3133-3134.1999

14. 14.

    Mooi F. R., van Oirschot H., Heuvelman K., van der Heide H. G., Gaastra W., Willems R. J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998;66(2):670-675.

    Not in our library10.1128/iai.66.2.670-675.1998

15. 15.

    Nagel J., Poot-Scholtens E. J. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol. 1983;16(4):417-426.

    Not in our library10.1099/00222615-16-4-417

16. 16.

    Nagel J., de Graaf S., Schijf-Evers D. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev Biol Stand. 1985;61:325-330.

    Not in our library

17. 17.

    Ramsay M. E., Farrington C. P., Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect. 1993;111(1):41-48.

    Not in our library10.1017/s095026880005665x

18. 18.

    de Melker H. E., Conyn-van Spaendonck M. A., Rümke H. C., van Wijngaarden J. K., Mooi F. R., Schellekens J. F. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis. 1997;3(2):175-178.

    Not in our library10.3201/eid0302.970211

19. 19.

    de Melker H. E., Versteegh F. G., Conyn-Van Spaendonck M. A., Elvers L. H., Berbers G. A., van Der Zee A., Schellekens J. F. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38(2):800-806.

    Not in our library10.1128/jcm.38.2.800-806.2000

20. 20.

    van de Water H. P. Kinkhoestaangiften in Nederland in de periode 1976-1986 en de noodzaak van een uniforme ziektedefinitie. Ned Tijdschr Geneeskd. 1988;132(18):821-828.

    Not in our library

21. 21.

    van de Water H. P., van de Laar M. J., Leentvaar-Kuijpers A. Wanneer is het kinkhoest? Verband tussen laboratoriumdiagnostische bevindingen en klachten. Ned Tijdschr Geneeskd. 1988;132(18):828-833.

    Not in our library

22. 22.

    van der Zee A., Agterberg C., Peeters M., Mooi F., Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis. 1996;174(1):89-96.

    Not in our library10.1093/infdis/174.1.89

23. 23.

    van der Zee A., Vernooij S., Peeters M., van Embden J., Mooi F. R. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 1996;142(Pt 12):3479-3485.

    Not in our library10.1099/13500872-142-12-3479

Cited by papers we hold 3

• Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study · 2021
  Not checked
• Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis · 2010
  No notice
• Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence · 2009
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.